Method for treating amyotrophic lateral sclerosis
US5780489A · kind A · utility
17Cited by
11References
22Claims
0Family size
Inventor
Key dates
| Filing date | Aug 21, 1996 |
| Grant date | Jul 14, 1998 |
| Priority date | — |
| Expiry date | Aug 21, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method for treating amyotrophic lateral sclerosis in a patient which comprises administering to the patient an effective amount of a non-cysteine glutathione precursor or a glutathione derivative so as to increase the intracellular glutathione levels and alleviate a symptom of amyotrophic lateral sclerosis. The non-cysteine substrate may be a thiazolidine-4-carboxylate analog, a thiazolidine-4-carboxylate analogs ester, or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.